Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Question for Chianchin (comments from others also welcome)
View:
Post by jamesfc on Jul 06, 2021 2:19am

Question for Chianchin (comments from others also welcome)

I have to agree with much of what you say on this board -- it's hard to see how anyone can deny that GUD has been a terrible investment up to this point.  However, the company does hold something like $3/share in cash; in your opinion, is there a point at which the stock price WOULD justify an investment?  I am starting to think it's getting close to that point, but would be interested to hear your thoughts.  Cheers.
Comment by Chianchin on Jul 06, 2021 6:39am
Jame, how many times can you cry wolf and expect help? GUD has looked attractive for eight  long mean Years. Yet it has never delivered  and lost 50% market cap. I can accept a MNGT faillure as any MNGT can end up doing and investors loosoing money. What is vulgar is some persons on this board/forum keeps presenting GUD as a success story over and over again while reality is 100% the ...more  
Comment by MrMugsy on Jul 06, 2021 7:56am
Sorry James, you're on your own with that guy ... He tried to convince us he was a little old lady from mainland China (see his first message) so not sure what his purpose even is here - but I have no respect for that approach. He's never held shares (self confessed) nor has he discussed his plan for accumulation or entry. Complains about LATAM and sees no value there - yet, that's ...more  
Comment by Chianchin on Jul 06, 2021 8:58am
James if you are an astute investor I am sure I am sure you can tell the difference from a two Dollar coin to a three dollar coin. It is impossible to convince a delusional person that he/she is delusional 
Comment by longrun86 on Jul 06, 2021 12:24pm
Hi JamesFC, I am a fairly new shareholder to Knight (my holding period is now a few months). I am not an expert in the pharmaceutical industry; however, I was attracted to Knight based on the valuation and the fact that the Company had finally made a significant and transformational acquisition that would allow them to put the cash to work. My view of Knight and its prospects were based on a ...more  
Comment by MrMugsy on Jul 06, 2021 4:55pm
Well said Longrun! And that's what I believe investors here are expecting.  Valuations will come based on discounted cash flows.  Positive and growing cashflow will eventually self-fund projects.  That's a reasonable expectation from a seasoned team.
Comment by jamesfc on Jul 07, 2021 6:51am
Thanks to all for your thoughts/input -- much appreciated.  James
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities